Search Results

Showing results 1361 - 1370 for weill cornell connect patient portal

Request for Therapeutic Small Molecule Proposals - Letters of Intent due February 17, 2023 | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/events/request-therapeutic-small-molecule-proposals-letters-intent-due-february-17-2023

Coping strategies of HIV patients with peripheral neuropathy

...Portal Discover Research Clinical Trials Teach Medical Education Graduate Education MD-PhD Program Connect...

https://geneticmedicine.weill.cornell.edu/publications/coping-strategies-hiv-patients-peripheral-neuropathy

Inflammasome Agonists for Vaccine and Immunotherapy | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/inflammasome-agonists-vaccine-and-immunotherapy

Modified AAV5 Capsid for Enhanced Organ-Specific Gene Therapy Delivery | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/modified-aav5-capsid-enhanced-organ-specific-gene

Dihydronicotinamide Riboside Derivatives for the Treatment of Neurodegeneration and Neuronal Injury | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/dihydronicotinamide-riboside-derivatives-treatment

MicroRNA-708 as a Therapeutic Agent against Metastatic Breast Cancer | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/microrna-708-therapeutic-agent-against-metastatic

Evaluation of fibronectin gene expression by in situ hybridization

...Portal Discover Research Clinical Trials Teach Medical Education Graduate Education MD-PhD Program Connect...

https://geneticmedicine.weill.cornell.edu/publications/evaluation-fibronectin-gene-expression-situ-hybridization-differential-expression-fibronectin-gene

Genetic modification of neurons to express bevacizumab for local

...Portal Discover Research Clinical Trials Teach Medical Education Graduate Education MD-PhD Program Connect...

https://geneticmedicine.weill.cornell.edu/publications/genetic-modification-neurons-express-bevacizumab-local-anti-angiogenesis-treatment-glioblastoma

Point-of-care whole-exome sequencing of idiopathic male infertility

...Portal Discover Research Clinical Trials Teach Medical Education Graduate Education MD-PhD Program Connect...

https://geneticmedicine.weill.cornell.edu/publications/point-care-whole-exome-sequencing-idiopathic-male-infertility

Feasibility of a clinical trial of augmentation therapy for

...Portal Discover Research Clinical Trials Teach Medical Education Graduate Education MD-PhD Program Connect...

https://geneticmedicine.weill.cornell.edu/publications/feasibility-clinical-trial-augmentation-therapy-alpha1-antitrypsin-deficiency-alpha-1-antitrypsin

Showing results 1361 - 1370 for weill cornell connect patient portal